MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2023 International Congress

    Alterations in Cortico-basal ganglia Directed Connectivity in Parkinsonism and during Therapeutic STN DBS

    B. Mohanty, J. Wang, L. Johnson, J. Vitek (Minneapolis, USA)

    Objective: Characterize the changes in oscillatory activity and connectivity in the basal ganglia thalamocortical (BGTC) network after induction of parkinsonian and during therapeutic deep brain…
  • 2023 International Congress

    Botulinum toxin-A in head and upper extremities tremor. A hand-made option

    H. Shehata, M. Shehata, M. Basheer, A. Elmazny, N. Shalaby (Cairo, Egypt)

    Objective: This was a 24-week open-label study to assess the role of BoNT-A injections for various types of hand and head tremor Background: Focal treatment…
  • 2023 International Congress

    The Impact of Diabetes Mellitus on Motor and Non-Motor Symptoms of Parkinson’s Disease: A Cross-Sectional Study.

    IC. Rodriguez-Gonzalez, F. Botello-Villagrana, SR. Gomez-Villalobos, A. Gonzalez-Cantu, X. Torres-Mancilla, M. Gonzalez-Gonzalez, D. Martinez-Ramirez (Monterrey, Mexico)

    Objective: To evaluate the impact of Diabetes Mellitus on the clinical characteristics and symptoms of Parkinson's Disease. Background: Parkinson's disease (PD) is a prevalent neurodegenerative…
  • 2023 International Congress

    Levodopa Carbidopa Intestinal Gel for Parkinson’s Disease over 11 years: A Single Center “Real-World” Experience

    C. Vekhande, M. Hamed, G. Tremain, J. Mah, A. Shetty, A. Lazarescu, O. Suchowersky (Edmonton, Canada)

    Objective: To review long-term real-world experience and clinical outcomes in PD patients with LCIG therapy over 11 years in a multidisciplinary University clinic setting. Background:…
  • 2023 International Congress

    Determinants of quality of life and daily mobility in Parkinson’s disease: the role of fear of falling.

    A. Magliozzi, V. Pozzilli, G. Sergi, V. Di Lazzaro, M. Marano (Roma, Italy)

    Objective: We aimed to investigate the relationship between the PD clinical features, the presence of FOF and its impact on QoL. We explored whether the…
  • 2023 International Congress

    Use of the Dysphagia Handicap Index (DHI) patient reported outcomes measure in Parkinson disease and cervical dystonia

    A. Silbergleit (Birmingham, USA)

    Objective: Objective: To demonstrate the value of using the DHI in movement disorders clinics. Background: Background: Dysphagia has a negative effect on work, leisure, and…
  • 2023 International Congress

    Subacute Encephalopathy with Seizures in Alcohol Consumers (SESA) presenting as Focal Dyskinesias and Myoclonus

    D. Desai, S. Desai (Anand, India)

    Objective: The purpose of this case series is to describe the clinical and electrophysiological features of SESA syndrome presenting as focal seizures mimicking dyskinesias and…
  • 2023 International Congress

    Resolving missing data from the MDS-UPDRS: implications for telemedicine

    S. Luo, C. Goetz, D. Choi, S. Aggarwal, T. Mestre, G. Stebbins (Durham, USA)

    Objective: The aim of this study was to determine imputation accuracy for total-sum and item-specific MDS-UPDRS Part III (Motor Examination) scores in remote administration. Background:…
  • 2023 International Congress

    Characteristics of Pain in Parkinson’s Disease with Arabic translation and validation of King’s Parkinson’s Disease Pain Scale

    T. Roushdy, E. Hamid, H. Salem, S. Reda, A. Shalash (cairo, Egypt)

    Objective: To translate and validate the King’s Parkinson’s Disease Pain Scale (KPPS) into Arabic and to correlate pain among PD patients with motor and non-motor…
  • 2023 International Congress

    A strategic training framework for building research capacity in the Global Parkinson’s Genetics Program (GP2)

    MT. Periñan, S. Dey, C. Bale, M. Kuhl, H. Leonard, P. Lewis, S. Stott, MB. Makarious, A. Martinez-Carrasco, AJ. Noyce, S. Bandres-Ciga, GP2. Genetics Program (Seville, Spain)

    Objective: To promote and facilitate learning internationally with resources and expertise to serve the training needs of the Global Parkinson’s Genetics Program (GP2;www.gp2.org) and its…
  • « Previous Page
  • 1
  • …
  • 37
  • 38
  • 39
  • 40
  • 41
  • …
  • 186
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • #23285 (not found)
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley